Scientists test drug duo to fight tough cancers
NCT ID NCT02379416
Summary
This early-stage trial tested whether combining two cancer drugs—nilotinib and paclitaxel—is safe for people with advanced solid tumors that haven't responded to standard treatments. Researchers enrolled 47 adults and some teenagers to find the highest dose that could be given safely. The study focused on safety and how the drugs work together in the body, not on whether they effectively shrink tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.